EUVIMEDEUVIMED entdecken
Crossref

In Silico Discovery of SARS-CoV-2 Main Protease Inhibitors Using Docking, Molecular Dynamics, and Fragment Molecular Orbital Calculations

Takeshi Ishikawa iD, Kenji Matsumoto, Toshiyuki Hamada iD, Hinako Koze, Masanori Baba, Mika Okamoto, Masayuki Sudoh

The Journal of Physical Chemistry B · 2025

DOI: 10.1021/acs.jpcb.4c07920 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Physical Chemistry B, 2025. Verfasst von Takeshi Ishikawa und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Biotechnology, and Chemical Engineering, Graduate School of Science and Engineering, Kagoshima University, 1-21-40 Korimoto,…. Hauptthemen laut MEDLINE: Molecular Dynamics Simulation, Coronavirus 3C Proteases, SARS-CoV-2, Protease Inhibitors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Molecular Dynamics SimulationCoronavirus 3C ProteasesSARS-CoV-2Protease InhibitorsAntiviral AgentsMolecular Docking SimulationHumansDrug DiscoveryHydrogen Bonding

Substanzen

Coronavirus 3C ProteasesProtease Inhibitors3C-like proteinase, SARS-CoV-2Antiviral Agents

Autor:innen und Institutionen

  • Department of Chemistry, Biotechnology, and Chemical Engineering, Graduate School of Science and Engineering, Kagoshima University, 1-21-40 Korimoto, Kagoshima 890-0065, Japan.
  • Department of Chemistry, Graduate School of Science and Engineering, Kagoshima University, 1-21-35 Korimoto, Kagoshima 890-0065, Japan.
  • Division of Infection Control Research, Center for Advanced Science Research and Promotion, Kagoshima University, 1-21-24, Korimoto, Kagoshima 890-8580, Japan.
  • Department of Translational Research, Joint Research Center for Human Retrovirus Infection, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8544, Japan.

ORCID-Profile: Takeshi Ishikawa, Toshiyuki Hamada

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Ishikawa, T., Matsumoto, K., Hamada, T., Koze, H., Baba, M., Okamoto, M., & Sudoh, M. (2025). In Silico Discovery of SARS-CoV-2 Main Protease Inhibitors Using Docking, Molecular Dynamics, and Fragment Molecular Orbital Calculations. The Journal of Physical Chemistry B. https://doi.org/10.1021/acs.jpcb.4c07920

Vancouver

Ishikawa T, Matsumoto K, Hamada T, Koze H, Baba M, Okamoto M, et al. In Silico Discovery of SARS-CoV-2 Main Protease Inhibitors Using Docking, Molecular Dynamics, and Fragment Molecular Orbital Calculations. The Journal of Physical Chemistry B. 2025. doi:10.1021/acs.jpcb.4c07920

BibTeX
@article{Ishikawa2025,
  author = {Ishikawa, Takeshi and Matsumoto, Kenji and Hamada, Toshiyuki and Koze, Hinako and Baba, Masanori and Okamoto, Mika and Sudoh, Masayuki},
  title = {In Silico Discovery of SARS-CoV-2 Main Protease Inhibitors Using Docking, Molecular Dynamics, and Fragment Molecular Orbital Calculations},
  journal = {The Journal of Physical Chemistry B},
  year = {2025},
  doi = {10.1021/acs.jpcb.4c07920}
}
Kostenlos starten →